Moneycontrol Be a Pro
Get App
SENSEX NIFTY
you are here:

Thyrocare Technologies Ltd.

BSE Live

Dec 11, 16:00
532.95 -4.05 (-0.75%)
Volume
AVERAGE VOLUME
5-Day
4,424
10-Day
3,446
30-Day
3,713
2,972
  • Prev. Close

    537.00

  • Open Price

    540.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Dec 11, 15:53
532.55 -4.20 (-0.78%)
Volume
AVERAGE VOLUME
5-Day
56,287
10-Day
36,376
30-Day
42,821
22,235
  • Prev. Close

    536.75

  • Open Price

    536.35

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    532.55 (1)

ANNOUNCEMENTS ON Thyrocare Techn

  • Dec 09, 2019 9:56 Source: NSE

    Thyrocare Technologies Limited

    Thyrocare Technologies Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates.

  • Dec 07, 2019 10:54 Source: BSE

    Thyrocare Technologies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the following forthcoming Analyst Meetings: i) Meeting with the representative(s) of Banyan Capital Advisors LLP, at 11.30 A.M. on Monday, December 09, 2019. ii) Meeting with the representative(s) of PhillipCapital (India) Pvt. Ltd., at 03.30 P.M. on Wednesday, December 11, 2019. iii) Meeting with the representative(s) of Arisaig Partners, at 11.00 A.M. on Monday, December 16, 2019. iv) Meeting with the representative(s) of Spark Capital Advisors (I) Pvt. Ltd., at 11.00 A.M. on Tuesday, December 17, 2019, to be followed by a visit by them to our lab. Please note that these are subject to any last minute changes.

  • Dec 02, 2019 18:39 Source: BSE

    Thyrocare Technologies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you about the forthcoming Con-call / Analyst Meeting to be held as follows; i) Con-call with the representative(s) of Nippon India Mutual Fund, at 04.00 P.M. on Tuesday, December 03, 2019. ii) Meeting with the representative(s) of ADD Capital, at 03.30 P.M. on Wednesday, December 04, 2019, at the corporate office of the Company. Please note that these are subject to any last minute changes.

  • Nov 28, 2019 18:52 Source: BSE

    Thyrocare Technologies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the representative(s) of InvesQ Investment Advisors would be having a meeting with us at 11.00 A.M. on Friday, November 29, 2019 at the Corporate Office of the Company. Please note that this is subject to any last minute changes.

  • Nov 20, 2019 12:41 Source: NSE

    Thyrocare Technologies Limited

    Thyrocare Technologies Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates

  • Nov 08, 2019 17:36 Source: BSE

    Thyrocare Technologies - Board declares Interim Dividend

    Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 07, 2019, inter alia, have approved payment of interim dividend for the financial year 2019-20, at the rate of Rs. 5.00 (Rupees Five only) per share (50% of the face value of Rs. 10/- each).

  • Nov 07, 2019 19:59 Source: BSE

    Thyrocare Technologies - Announcement under Regulation 30 (LODR)-Investor Presentation

    We are forwarding copy of Presentation on Quarterly Results of our company for the quarter / half year ended 30-09-2019. Please note that this is only uploaded in our website, and has not been distributed or advertised in newspapers or otherwise publicised.

  • Nov 07, 2019 19:29 Source: BSE

    Thyrocare Technologies - Outcome of Board Meeting

    Kindly note that the Board Meeting held today to consider and approve unaudited financial results of the Company (both Stand-alone and Consolidated) for the quarter/half year ended 30-09-2019, commenced at 17.30 hrs and ended at 19.00 hours.

  • Oct 30, 2019 12:51 Source: BSE

    Thyrocare Technologies - Board Meeting Intimation for 1. Unaudited Financial Results (Stand-Alone And Consolidated) For The Quarter/Half Year Ended 30-09-2019.
    2. Interim Dividend, If Any.
    3. Other Subjects, If Any.

    Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a meeting of our Board of Directors of the Company will be held on Thursday, November 07, 2019, at the Corporate Office of the Company, inter alia, to consider and approve Unaudited Stand-alone and Consolidated Financial Results of the Company for the quarter / half year ended September 30, 2019 and to consider payment of interim dividend, if any. Intimation of the above meeting of the Board of Directors is also being published in newspapers, as required under Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

  • Oct 19, 2019 13:00 Source: BSE

    Thyrocare Technologies - Compliance Certificate For The Quarter Ended 30-09-2019 Under Regulation 40 (9) Of Securities & Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations, 2015.

    We are filing herewith Compliance Certificate dated 17-10-2019 issued by Mr. V. Suresh, Practising Company Secretary, pursuant to the Regulation 40 (9) of Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the Half-year ended September 30, 2019. Please take the same on record.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Nov 07, 2019
Remark : Quarterly Results & Interim Dividend